On this page
Balfaxar
Prothrombin complex concentrate, human-lans
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Balfaxar
Proper name
Prothrombin complex concentrate, human-lans
Licence type
351(a)
BLA number
125776
Applicant
Octapharma Pharmazeutika Produktionsges.m.b.H.
Center
CBER
Presentations
2
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 1000IU | For Injection | Intravenous | Single-Dose Vial | Rx | July 21, 2023 |
| 500IU | For Injection | Intravenous | Single-Dose Vial | Rx | July 21, 2023 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |